Comparing medications to reduce bleeding in heart surgery
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled for heart surgery that uses a heart-lung machine.
- You are not pregnant.
- Your surgery is not an emergency.
- You do not have a weakened immune system, end-stage kidney disease, or serious liver disease.
- Your surgery is not on the aorta, and you are not in critical condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving tranexamic acid at different times during heart surgery can reduce blood loss and the risk of seizures. It may help patients who need certain types of heart surgery with a heart-lung machine.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This study compares two ways of giving tranexamic acid, a medicine that helps reduce bleeding, to people having heart bypass surgery without a heart-lung machine. It aims to see if taking the medicine as a pill is as good as getting it through an IV line.
This trial tests whether a medicine called tranexamic acid can help reduce the need for blood transfusions during major abdominal surgeries. It's for people having surgery to remove part of the esophagus, stomach, colon, rectum, pancreas, or liver.
This trial tests whether a medicine called tranexamic acid can safely reduce bleeding during surgery in very obese patients who also have other health conditions. If you are scheduled for surgery and meet the criteria, this could help prevent excessive blood loss.
Hear when a new Cardiopulmonary Bypass trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.